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Background and purpose: The purpose of this study was to add, to the objective evaluation, an instrumental
assessment of the skin damage induced by radiation therapy.
Materials and methods: A group of 100 patients affected by breast cancer was recruited in the study over one
year. Patients were divided into five groups of 20 patients. For each group it was prescribed a different topical
treatment. The following products were used: Betaglucan, sodium hyaluronate (NeovidermW), Vitis vinifera A. s-I-M.t-
O.dij (IxodermW), Alga Atlantica plus Ethylbisiminomethylguaicolo and Manganese Cloruro (Radioskin1W) and Metal
Esculetina plus Ginko Biloba and Aloe vera (Radioskin 2W); Natural triglycerides-fitosterols (XderitW); Selectiose plus
thermal water of Avene (Trixera+W). All hydrating creams were applied twice a day starting 15 days before and one
month after treatment with radiations. Before and during treatment patients underwent weekly skin assessments
and corneometry to evaluate the symptoms related to skin toxicity and state of hydration. Evaluation of acute
cutaneous toxicity was defined according to the RTOG scale.
Results: All patients completed radiotherapy; 72% of patients presented a G1 cutaneous toxicity, 18% developed a
G2 cutaneous toxicity, 10% developed a G3 toxicity, no one presented G4 toxicity. The corneometry study
confirmed the protective role of effective creams used in radiation therapy of breast cancer and showed its
usefulness to identify radiation-induced dermatitis in a very early stage.
Conclusions: The preventive use of topic products reduces the incidence of skin side effects in patients treated
with radiotherapy for breast cancer. An instrumental evaluation of skin hydration can help the radiation oncologist
to use strategies that prevent the onset of toxicity of high degree. All moisturizing creams used in this study were
equally valid in the treatment of skin damage induced by radiotherapy.
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Table 1 Characteristics of patients enrolled in the study








dry skin 56 (56%)
normal skin 10 (10%)
sensible skin 34 (34%)
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The most important aspects in the management of radi-
ation–induced skin reactions are prophylaxis and, when
they appear, their appropriate treatment. Breast cancer
has an high incidence rates in Italy, and it is the first
cause of cancer death in women [1]. Screening programs
increased the diagnosis of breast tumors in the initial
stage and then survival [2]. Every year about 35,000 new
cases are diagnosed and 80% of these being treated in
Italian Radiotherapy Centers [3]. A great number of pa-
tients are submitted to adjuvant radiotherapy after sur-
gery with or without chemotherapy. In the course of
radiotherapy, skin toxicity remains an important clinical
problem for many patients. The severity of the acute
toxicity is related to several factors: dose per fraction,
total delivered dose, location and volume of the treated
area, radiating energy, other treatments received con-
comitantly or before. The literature shows individual vari-
ations depending on age, chronic diseases, skin types,
genetic predisposition, skin damage from the previous and
concomitant drug therapy (cytotoxic chemotherapy) [4,5].
However, it is difficult to estimate the frequency and
intensity of these adverse effects. Temporary skin reac-
tions vary from mild erythema to brisk moist desquam-
ation. At present, guidelines regarding skin care during
the course of radiotherapy remain inconsistent. More-
over all treatments remain linked to a subjective
evaluation of the patient that the specialist involved
(Dermatologist, Radiation Oncologist, Surgeon or Med-
ical Oncologist) performs, in the majority of cases with-
out a multidisciplinary evaluation [6].
Our treatment policies provide a prophylactic use of a
topical therapy to prevent skin damages. The purpose of
this study was to add to the subjective evaluation of the
topical therapy, an instrumental measurement for the as-
sessment of skin damage induced by radiation therapy.
Methods and material
From January 2011 to December 2011 we enrolled a
group of 100 consecutive female patients, aged from 29
to 75 years (median age 59) with a pathologic diagnosis
of breast cancer. Were included in the study patients
treated with conservative surgery (quadrantectomy), sur-
gical margins were free of disease, and there wasn’t indi-
cation for regional nodal radiation therapy (less than
four nodes involved) according to our national guide-
lines [7]. Therefore they were candidates for adjuvant
radiotherapy with 6 MV photons, with a dose of 50 Gy
(2Gy/fraction) to whole breast with tangential fields, and
a subsequent additional dose of 10 Gy (2Gy/fraction) to
the tumor bed [8]. All patients were submitted to a
simulation Simulation CT-Scan, the three-dimensional
treatment plan was set with the PinnacleW TPS system,
the target volumes were delineated according to thecriteria of the International Commission on Radiation
Units [9,10].
In our Department is active from 2010 a multidiscip-
linary ambulatory in which Dermatologists and Radi-
ation Oncologists can visit the patients at the same time.
In Table 1 shows the characteristics of the patients.
Seventy-two of these patients were of phototype II and
28 of phototype III according to the Fitzpatrick classifi-
cation (Table 2) [11]; 56 patients had dry skin, 34 sens-
ible skin and 10 normal skin.
Patients were randomized into five groups. Each group
received the prescription of a prophylactic moisturizing
cream.
Topical treatments prescribed to five groups were as
follows:
Group A = Betaglucan, sodium hyaluronate
(NeovidermW)
Group B = Vitis vinifera A. s-I-M.t-O.dij (IxodermW)
Group C = Alga Atlantica and
ethylbisiminomethylguaicolo Manganese Cloruro
(Radioskin 1W) and metal esculetina, ginko biloba and
Aloe vera (Radioskin 2W)
Group D = Natural triglycerides-fitosterols (XderitW)
Group E = Selectiose, thermal water of Avene (Trixera+W)
Patients were evaluated, with corneometry, by derma-
tologists before and during radiotherapy and clinically
together with radiation oncologists. At that moment of
the CT Simulation they were instructed to apply cream
topically every day (2–3 times/day) before (least 3 hours
before) and after the radiotherapy treatment. They
started radiation therapy medially 15 days after the be-
ginning of the topical treatment and it was indicate to
use the products also 1 month after the end of treat-
ment. Moreover, during radiotherapy it was prohibited to
use other types of creams or perfumes on the irradiated
skin. Patients were asked not to apply the creams within 3
hours before radiation treatment and were educated to
Table 2 Human skin Phototypes (Fitzpatrick TB)
I White Always burn easily, never tans
II White Always burn easily, tans minimally and with difficulty
III White Burns minimally, gradually and uniformly
IV Light brown Burns minimally, always tans well
V Brown Rarely burns, tans profusely
VI Dark brown or black Never burns, tans profusely
Di Franco et al. Radiation Oncology 2013, 8:57 Page 3 of 7
http://www.ro-journal.com/content/8/1/57carefully wash the area only with special oil soap and to
wear loose clothes, preferably made of cotton.
The patients were subjected to clinical examination
plus Corneometry: 1) at the time of CT simulation, and
2) every week during treatment and 3) 1 month after the
end of therapy. The evaluation was carried out jointly by
the radiation oncologist and dermatologist. The radi-
ation oncologist evaluated the radiodermatitis, according
to the RTOG scale, the dermatologist evaluated the hy-
dration of the skin with corneometry. The clinical exam-
ination consisted of physical examination of the breast
skin, the corneometry measured numerically skin hydra-
tion. During treatment with radiotherapy, local side-
effects were recorded according to the RTOG scale [12].
Corneometer CMW 820 is a simple instrument that
measure the water content of the skin. The examination
is based on the measure of the ability of a dielectric
medium, so any change in the dielectric constant caused
by the change of hydration of the skin alters the
measurement supplied by the condenser [13]. The
corneometry provides an indirect measure of the barrier
function, and values of hydration of the skin are consid-
ered normal if included in the range 60–90 a.u.Results
Results were assessed not only in terms of grade and
overall reduction in toxicity but also in terms of full re-
gression of skin lesions with “ad integrum restitutio” and
in terms of rapidity of repair of radio-induced damage
assessed at 1 month after radiotherapy. At one month
after the end of radiotherapy in all patients of groups A,
B, C, E, it was recorded a G0 dermal toxicity. Eight pa-
tients in Group D had shown G1 toxicity. All patients
completed the radiotherapy, and G4 cutaneous toxicity
(according to RTOG scales (Table 3) was not observed
in any patients [8].Table 3 ROTG scale used
Grade 0 Grade 1 G
Light and/or painless erythema Sensitive and /
No changes Epilation Desq
Desquamation Partia
Dryness ModerThe percentage of patients who underwent systemic
therapies (chemotherapy, hormonal therapy and/or bio-
logical therapy) for each group are shown in Table 4.
The complete results of the measurement with cor-
neometry are shown in Table 5, that show the value of
moisture of the skin measured with a corneometer. In
general, corneometry values at starting point were be-
tween 40.5 (smallest median value) and 60.8 (highest
median value) and at the end of treatment were between
45.7 (smallest median value) and 70.8 (highest median
value). The low values of corneometry recorded at the
beginning of treatment are certainly due to the alteration
in skin of the breast treated surgically and any systemic
treatments provided in specific cases.
We evaluated the correlation between the values mea-
sured with the corneometry in the various groups and
systemic therapies carried out by the patients, in particu-
lar for each type of therapy (shown in Table 4) we evalu-
ated the absolute risk reduction (ARR), relative risk (RR)
and odds ratio (OR). We have not found a clear correl-
ation between systemic treatments and the values of
corneometry, probably for the small number of patients
examined.
Regarding the correlation of the measurement with
corneometry with the breast volumes, we found breast
volumes > 500 cc both in groups B and D. We can
hypothesize a correlation between breast volumes of the
group D and skin toxicity, but without a statistical sig-
nificance. The values of corneometry however were
similar in these groups, so we can’t describe a direct cor-
relation between the breast volumes, the corneometry
values and the local toxicities.
Group A
Of the 20 patients, 18 showed G1 toxicity and 2 G2 tox-
icity during radiotherapy. All patients had a good grade
of hydration measured with a corneometer, also at therade 2 Grade 3 Grade 4
or intense erythema Desquamation Ulceration
uamation Widespread sweating Haemorrhage
l sweating Marked edema Necrosis
ate edema
Table 4 Percentage of patients treated with systemic therapies (chemo therapy CT, hormonal therapy OT and
biological therapy BT) and breast volume for each group
CT % OT% BT% Breast Volume > 500 cc Breast Volume ≤ 500 cc
Group A 50% 75% 14% 58% 42%
Group B 66% 66% 28% 60% 40%
Group C 40% 40% 20% 24% 76%
Group D 43% 85% 12% 74% 26%
Group E 60% 60% 25% 42% 58%
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courage and speed up the regeneration and quickens the
healing of irradiated skin. The level of skin elasticity and
skin dryness is good.
Group B
Of the 20 patients 16 showed G1 toxicity and 4 G2 tox-
icity during radiation therapy. Measurement of hydra-
tion showed a value of moisture of the skin with a slight
decrease during the therapy and at the first follow up.
Group C
Of these patients 19 manifested G1 and 1 G2 toxicity at
the conclusion of radiotherapy. The measurement with a
corneometer emphasized the effective role of moisturiz-
ing cream. The Alga Atlantica has a central role in pro-
tection the skin’s microcapillary integrity.
Group D
Of 20 patients, 4 had G1 toxicity, 8 a G2 toxicity and 5 a
G3 toxicity during the radiation treatment. Eight pa-
tients who suffered cutaneous toxicity during the treat-
ment also showed G1 toxicity at the first follow up.
Group E
Of the 20 patients, 15 had a G1 cutaneous toxicity, 5 a
G2 toxicity. Selectiose has a role in inflammatory reac-
tions. Avene thermal water and glycin modulate itch and
reddening.
The results concerning the average value of
corneometry and dermal toxicity (RTOG), obtained in
the five groups, are shown in the following graphics
(Figure 1, Figure 2):
The measurement with a corneometer confirmed the
protective role of effective creams used in our
Departmets routinely during radiation therapy of breastTable 5 Median of corneometry value at start and end of the
Group A Group B Group
Start 40.6 Start 40.2 Start 4
(range 32.7 - 44.6) (range 30.9 – 42.2) (range 31.08
End 70.8 End 75.7 End 65
(range 39.5 - 71.9) (range 37.2 – 77.0) (range 38.6cancer. This allowed us to identify radiation induced
dermatitis in a very early stage compared to only object-
ive examination by allowing to treat early stage patients
with a greater hydration or with steroid creams to inter-
vene with early onset of erythema.
Discussion
Skin side-effects, using radiotherapy techniques, are a
common consequence of radical doses of radiotherapy,
and many products have been introduced in order to
prevent such side effects. Now radiation techniques have
been improved but concomitantly there is a wider atten-
tion on the problems linked to skin irradiation. Cur-
rently, there is no standard approach for the prevention
and treatment of radio-induced skin lesions, although
several studies have been published on the use of various
kinds of topical agents [14,15]. Patients with breast can-
cer are increasing and their call for help expresses the
need for new medical equipment. There is a growing at-
tention on the local side effects of therapies in the field
of oncology, and radiotherapy above all, also because
there is an increasing request by these patients, to pre-
serve as much as possible their physical aspect. Despite
the common occurrence of radiation skin toxicity, there
are very few trials on the argument.
In our study, we show that a good hydration of the
skin before, during and after radiotherapy treatment can
have a positive effect on the skin tolerance of treatment.
In our clinical practice we use to prescribe moisturizers
to all patients with an indication for radiotherapy for
breast cancer. In fact we believe that a preventive ther-
apy of the skin side effects is more effective than a treat-
ment of the local side effects once they appear. This
approach shows significant effectiveness in reducing the
onset of acute dermal toxicity. Moreover, the radiother-
apy treatments were well tolerated by patients and norapy
C Group D Group E
2.6 Start 41.8 Start 40.7
– 44.6) (range 33.8 – 42.0) (range 34.3 – 43.5)
.8 End 70.9 End 70.9
– 68.0) (range 39.0 – 72.1) (range 38.4 – 73.2)
Figure 1 Mean Values of Corneometry at the start and the end of treatment.
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tions. Acute radiodermatitis may affect the patients’
quality of life and daily activities. In some cases, un-
planned gaps in treatment could occur, which decrease
treatment efficacy [16]. Apart from thorough skin
cleaning and prevention of local irradiation-induced
trauma, there is no well established protocol to prevent
skin radiation toxicity [17]. According to literature data
we know that there are some risk factors including con-
current therapy, the use of bolus and smoking, previous
or concomitant chemotherapy because of the change in
the smallest blood vessels [4,5].
In our experience we tested five different products in
one hundred patients. The formulations of creams used
showed good results. For all of them we received a satis-
factory result, with only five patients with a grade 3
dermatitis and twenty with a grade 2 dermatitis. It isFigure 2 Skin toxicity observed in the five groups of patients.impossible for us to draw a conclusion about the ques-
tion of what product is more active also because the
number of patients is too small and because there are
too many variables in the groups. In fact there are
personal differencies, of the phototypes, but also
differencies about the age of patients and the therapies
that they received before, such as chemotherapy, or after
surgery and concomitantly with radiotherapy, like
ormonal therapy. The largest number of patients with a
recorded skin toxicity a month after radiotherapy, in
group D of our study, can be related to the patient’s big-
gest breast volumes, although we do not have a statis-
tical significance. Moreover the values of corneometry
allow us to attribute a good moisturizing effect for prod-
ucts used in five groups of patients. Certainly the cre-
ation of a multidisciplinary team has allowed, with the
corneometry conducted at the same time of the clinical
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phase and to determine the appropriate treatment to
prevent the onset of dermatitis of high level which may
affect the tolerance of treatment for these women.
The first physiopathological step of radiation toxicity
to the skin is known to be an overproduction of free rad-
icals, which is responsible for damage to the basal epi-
dermis layer cells and the endothelial cells. Degradation
of the latter cells induces a perivascular inflammatory in-
filtrate around dilated blood vessels. Degradation of the
former cells (proliferative layer) induces the transcrip-
tion of pro-inflammatory cytokines, which are respon-
sible for the inflammatory cascade. As a consequence of
those effects, early radiodermatities are clinically ob-
served [18-20]. The physiopathology of moist desquam-
ation involves the loss of basal layer cells of epidermis.
Erythema reflects an inflammatory response and a dam-
age to basal layer cells. Aloe vera could be used to limit
erythema, leading to an overall lower skin toxicity score.
In literature, the prophylactic or therapeutic use of top-
ical betamethasone is often present. The evaluation of
skin side effects during and after a radiotherapy treat-
ment normally is a clinical evaluation and it represents a
subjective point of view of the phenomenon. In our
study, we have combined clinical examination with
corneometry. Although it is a measure of the water con-
tent of the skin, it is only an indirect measure of barrier
function. However, there is a good relationship between
numeric value and the extent of hydration under various
physiological and pathological phenomena. Since water
loss through the skin normally occurs by passive diffu-
sion through the epidermis, smaller values indicate
greater water loss and are consistent with increased
damage of the barrier function of the stratum corneum
[21-23]. Use of Corneometer to study water content of
the skin is valid because of the skin has mechanic prop-
erties in relationship to hydration state; so a dry skin will
be less elastic than moisturized skin. The assessment
“in vivo” of the hydration is very important for clinical
and experimental evaluation of the real capacity of a
cream to moisturize skin and repair skin barrier. Some
patients started radiotherapy already with low hydration
value probably because of the chemotherapy treatment
received before radiotherapy. Women treated for breast
cancer request a satisfactory aesthetic condition accor-
ding to a resolution of oncologic problems. It was
impossible for us with a small number of patients, to
evaluate which is the best product of the five used.
Conclusions
Our study confirms that moisturizers have an important
value in the prevention of radiotherapy-induced skin
damage and indicates that an instrumental assessment
of skin hydration can help the radiation oncologist touse strategies that prevent the onset of toxicity of high
degree.
Today it is ethically unacceptable to wait for the appear-
ance of side effects to treat them. The prevention is re-
quired. Our patients receive a positive relationship with
the radiation, which occurs after surgery and sometimes
after chemotherapy, because they feel that the oncology
team seeks to preserve their femininity. The interaction
between medical specialties (Dermatology and Radiother-
apy) has been valuable in this experience and has brought
added value to the benefit of our patients.
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